|
|
||||||||
|
|
|||||||||
|
|
Technologist Student AbstractsTechnologist Student Papers II |
1 Nuclear Medicine Technology Program, Indiana U, Indianapolis, Indiana; 2 Radiology Dept., Indiana U Hospital, Indianapolis, Indiana
2216
Objectives: Pulmonary nodules are often difficult to biopsy for diagnosis and results are not always accurate. Positron Emission Tomography (PET) scans using the radioactive tracer Fluorodeoxyglucose (FDG) have become a new tool in assessing risk of malignancy in these nodules. Current literature has indicated a SUV cutoff of 2.5 as the upper limit for benign conditions. If a scan could consistently discriminate between benign and malignant conditions, the need for further diagnostic testing and patient discomfort could be eliminated.
Methods: During the study period, we identified patients who had been referred for indeterminate pulmonary nodules on chest x-ray or Computed Tomography (CT) and were scanned using FDG-PET. Data were reviewed by staff radiologists. Data included the assessment of SUV as well as a visual impression characterized by low, moderate or high probability of malignancy, inflammation, infectious process, or indeterminate diagnosis. FDG-PET SUV results and, separately, visual results were compared retrospectively with histology and follow-up.
Results: Thirty nodules were malignant and 30 were benign. Four nodules were still considered indeterminate after fine needle aspiration (FNA) biopsy. SUV indicated a sensitivity of 70% and specificity of 78% for detection of benign conditions with a negative predictive value of 75%. Visual analysis scored higher with a sensitivity and specificity of 90.3% and 86.6% respectively, and a negative predictive value of 86.2%.
Conclusions: FDG-PET SUV is a helpful tool but cannot rule out the possibility of false negatives. Greater accuracy by radiologist readers means that PET should still be utilized as a preliminary step prior to more invasive procedures.
| ||||||||||||||||||||||||||||||||||||||